Replies to post #47687 on Ayala Pharmaceuticals Inc (ADXS)

[BarrellofHay]

So in other words we have a 16% survival rate after 40 months. Or is it longer than 40 months?

[Simple Steve]

Thank you Dewdiligence. So if I am understanding you correctly, there are a grand total of 50 patients who have entered the trial and been dosed. And out of those, 19 made it to 12 months. So even though the PR was issued in March 2017, the data was from Jan 31, 2017. And as of that date there were 8 patients alive. Ok that sounds like a plausible explanation. So can we assume no more patients after Jan 31, 2017? And so those will be the last updated results from Phase 2? Or I wonder if maybe they still track those patients. Just wondering out loud.